Medication Adherence Pattern for Benign Prostatic Hyperplasia: A Cross-Sectional Study
Abstract
Introduction: Benign prostate hyperplasia is one of the most common diseases and a common cause of lower urinary tract symptoms in aging men. Various disease management approaches to optimize the patient’s long life and efficient status where patient adherence to the prescribed treatment plays a vital role. This study evaluated the medication adherence pattern of the patients to obtain successful treatment outcomes. Methods: A cross-sectional study was conducted in out-patient department of urology in a tertiary care hospital. Patients diagnosed with benign prostate hyperplasia were interviewed using a structured questionnaire. Results: The high expenses of medicine, fear of medication, lack of symptomatic relief were factors that showed statistically significant (p < 0.05) difference between adherent and non-adherent group. Similarly, the duration of diagnosis of the adherent group was significantly less than the non-adherent group including the pattern of physical activities (p < 0.05). Adherent group also had more participants working in business and services occupation compared to the non-adherent group. Conclusion: The general attitude (such as fear of medication and lack of symptomatic relief) is seen as major factors that affect adherent pattern in benign prostate hyperplasia patients. These issues can be solved using proper guidance. However, the cost of medicines also posts an immense issue for the non-adherent group.
Downloads
References
Kapoor A. Benign prostatic hyperplasia (BPH) management in the primary care setting. Can J Urol. 2012;19 Suppl 1:10-7. PMID: 23089343
Raza I, Hassan N, Jafri A, Gul P. Relationship between Benign Prostatic Hyperplasia and International Prostatic Symptom Score. British Journal of Medicine & Medical Research. 2015;10(5):1-9. Available from: https://www.researchgate.net/publication/281548975
Rył A, Rotter I, Miazgowski T, Słojewski M, Dołęgowska B, Lubkowska A, et al. Metabolic syndrome and benign prostatic hyperplasia: association or coincidence? Diabetol Metab Syndr. 2015;7(0):94. PMID: 26516352. DOI: https://doi.org/10.1186/s13098-015-0089-1
Eryildirim B, Aktas A, Kuyumcuoglu U, Faydaci G, Tarhan F, Ozgül A. The effectiveness of sildenafil citrate in patients with erectile dysfunction and lower urinary system symptoms and the significance of asymptomatic inflammatory prostatitis. Int J Impot Res. 2010;22(6):349-54. PMID: 20981108. DOI: https://doi.org/10.1038/ijir.2010.26
Cindolo L, Pirozzi L, Sountoulides P, Fanizza C, Romero M, Castellan P, et al. Patient’s adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy? BMC Urol. 2015;15:96. PMID: 26391357. DOI: https://doi.org/10.1186/s12894-015-0090-x
Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, et al. EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction. Eur Urol. 2013;64(1):118-40. PMID: 23541338. DOI: https://doi.org/10.1016/j.eururo.2013.03.004
Tripathi K. Essentials of medical pharmacology. 7th ed. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 2013. Available from: https://pharmacyfunblog.files.wordpress.com/2016/11/kd-tripathi-essentials-of-medical-pharmacologyunitedvrg-2013.pdf
Parsons JK, Palazzi-Churas K, Bergstrom J, Barrett-Connor E. Prospective study of serum dihydrotestosterone and subsequent risk of benign prostatic hyperplasia in community dwelling men: the Rancho Bernardo Study. J Urol. 2010;184(3):1040-4. PMID: 20643424. DOI: https://doi.org/10.1016/j.juro.2010.05.033
World Health Organization. Adherence to long-term therapies: Evidence for action. Geneva: World Health Organization. Report number: WHO/MNC/03.01, 2003. Available from: https://www.who.int/chp/knowledge/publications/adherence_introduction.pdf?ua=1
Central Intelligence Agency. The World Factbook [Internet]. Nepal: 2016. Available from: https://www.cia.gov/library/publications/the-world-factbook/geos/br.html
McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793- 803. PMID: 21420124. DOI: https://doi.org/10.1016/j.juro.2011.01.074
Yağmur I, Turna B, Tekin A, Akıncıoğlu E, Sarsık B, Ulman İ. Benign prostatic hyperplasia: Case report of a 17-year-old. J Pediatr Urol. 2016;12(4):267.e1-267.e4. PMID: 27593922. DOI: https://doi.org/10.1016/j.jpurol.2016.04.031
Parsons JK. Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors. Curr Bladder Dysfunct Rep. 2010;5(4):212-18. PMID: 21475707. DOI: https://doi.org/10.1007/s11884-010-0067-2
Windham GC, Mitchell P, Anderson M, Lasley BL. Cigarette Smoking and Effects on Hormone Function in Premenopausal Women. Environ Health Perspect. 2005;113(10):1285-90. PMID: 16203235. DOI: https://doi.org/10.1289/ehp.7899
Matzkin H, Soloway MS. Cigarette smoking: A review of possible associations with benign prostatic hyperplasia and prostate cancer. Prostate. 1993;22(4):277-90. PMID: 7684523. DOI: https://doi.org/10.1002/pros.2990220402
Parsons JK. Lifestyle factors, benign prostatic hyperplasia, and lower urinary tract symptoms.
Curr Opin Urol. 2011;21(1):1-4. PMID: 21045705. DOI: https://doi.org/10.1097/mou.0b013e32834100c9
Parsons JK, Messer K, White M, Barrett-Connor E, Bauer DC, Marshall LM, et al. Obesity Increases and Physical Activity Decreases Lower Urinary Tract Symptom Risk in Older Men: The Osteoporotic Fractures in Men Study. Eur Urol. 2011;60(6):1173-80. PMID: 21802828. DOI: https://doi.org/10.1016/j.eururo.2011.07.040
Muhammed S, Nagla S, Morten S, Asma E, Arja A. Illness perceptions and quality of life among tuberculosis patients in Gezira, Sudan. Afr Health Sci. 2015;15(2):385-93. PMID: 26124783. DOI: https://doi.org/10.4314/ahs.v15i2.11
Wabe N, Angamo M, Hussein S. Medication adherence in diabetes mellitus and self management practices among type-2 diabetics in Ethiopia. North Am J Med Sci. 2011;3(9):418-23. PMID: 22362451. DOI: https://doi.org/10.4297/najms.2011.3418
Kristal AR, Till C, Tangen CM, Goodman PJ, Neuhouser ML, Stanczyk FZ, et al. Associations of Serum Sex Steroid Hormone and 5-Androstane-3 ,17β-Diol Glucuronide Concentrations with Prostate Cancer Risk Among Men Treated with Finasteride. Cancer Epidemiol Biomarkers Prev. 2012;21(10):1823-32. PMID: 22879203. DOI: https://doi.org/10.1158/1055-9965.epi-12-0695
Liu L, Zhao S, Li F, Li E, Kang R, Luo L, et al. Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials. J Sex Med. 2016;13(9):1297-1310. PMID: 27475241. DOI: https://doi.org/10.1016/j.jsxm.2016.07.006
Sweileh WM, Zyoud SH, Abu Nab’a RJ, Deleq MI, Enaia MI, Nassar SM, et al. Influence of patients’ disease knowledge and beliefs about medicines on medication adherence: findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine. BMC Public Health. 2014;14:94. PMID: 24479638. DOI: https://doi.org/10.1186/1471-2458-14-94
Miller TA, DiMatteo R. Importance of family/ social support and impact on adherence to diabetic therapy. Diabetes Metab Syndr Obes. 2013;6(0)421-6. PMID: 24232691. DOI: https://doi.org/10.2147/dmso.s36368
De Nunzio C, Presicce F, Lombardo R, Trucchi A, Bellangino M, Tubaro A, et al. Patient centred care for the medical treatment of lower urinary tract symptoms in patients with benign prostatic obstruction: a key point to improve patients’ care – a systematic review. BMC Urol. 2018;18(1):62. PMID: 29940928. DOI: https://doi.org/10.1186/s12894-018-0376-x
Copyright (c) 2020 Jyoti Tara Manandhar Shrestha
This work is licensed under a Creative Commons Attribution 4.0 International License.
- The Journal of Lumbini Medical College (JLMC) publishes open access articles under the terms of the Creative Commons Attribution (CC BY) License which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- JLMC requires an exclusive licence to publish the article first in its journal in print and online.
- The corresponding author should read and agree to the following statement before submission of the manuscript for publication,
- License agreement
- In submitting an article to Journal of Lumbini Medical College (JLMC) I certify that:
- I am authorized by my co-authors to enter into these arrangements.
- I warrant, on behalf of myself and my co-authors, that:
- the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights;
- I am/we are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to JLMC are not in breach of any other obligation;
- the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy;
- I/we have taken due care to ensure the integrity of the article. To my/our - and currently accepted scientific - knowledge all statements contained in it purporting to be facts are true and any formula or instruction contained in the article will not, if followed accurately, cause any injury, illness or damage to the user.
- I, and all co-authors, agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0. If the law requires that the article be published in the public domain, I/we will notify JLMC at the time of submission, and in such cases the article shall be released under the Creative Commons 1.0 Public Domain Dedication waiver. For the avoidance of doubt it is stated that sections 1 and 2 of this license agreement shall apply and prevail regardless of whether the article is published under Creative Commons Attribution License 4.0 or the Creative Commons 1.0 Public Domain Dedication waiver.
- I, and all co-authors, agree that, if the article is editorially accepted for publication in JLMC, data included in the article shall be made available under the Creative Commons 1.0 Public Domain Dedication waiver, unless otherwise stated. For the avoidance of doubt it is stated that sections 1, 2, and 3 of this license agreement shall apply and prevail.
Please visit Creative Commons web page for details of the terms.
